Total Payments
$4,629
2024 Payments
$852.89
Companies
21
Transactions
160
Medicare Patients
866
Medicare Billing
$66,981
Payment Breakdown by Category
Food & Beverage$4,472 (96.6%)
Education$156.98 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,472 | 158 | 96.6% |
| Education | $156.98 | 2 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,763 | 74 | $0 (2024) |
| Celgene Corporation | $522.29 | 4 | $0 (2019) |
| Incyte Corporation | $361.29 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $332.65 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $253.85 | 6 | $0 (2024) |
| Lilly USA, LLC | $246.77 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $169.33 | 8 | $0 (2024) |
| UCB, Inc. | $169.08 | 5 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $137.50 | 2 | $0 (2024) |
| GENZYME CORPORATION | $130.75 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $852.89 | 32 | ABBVIE INC. ($234.68) |
| 2023 | $931.76 | 42 | AbbVie Inc. ($293.28) |
| 2022 | $972.45 | 46 | ABBVIE INC. ($473.14) |
| 2021 | $435.12 | 19 | AbbVie Inc. ($241.98) |
| 2020 | $120.29 | 5 | AbbVie Inc. ($71.86) |
| 2019 | $907.98 | 11 | Celgene Corporation ($387.14) |
| 2018 | $408.64 | 5 | AbbVie, Inc. ($251.75) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.30 | General |
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $12.08 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $32.72 | General |
| Category: Immunology | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.48 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $81.16 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.93 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $42.09 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Dermatology | ||||||
| 07/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.93 | General |
| Category: Dermatology | ||||||
| 06/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Immunology | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $122.54 | General |
| Category: Dermatology | ||||||
| 06/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 520 | 935 | $156,526 | $41,784 |
| 2022 | 9 | 275 | 523 | $76,147 | $19,415 |
| 2021 | 4 | 71 | 73 | $16,220 | $5,782 |
Total Patients
866
Total Services
1,531
Medicare Billing
$66,981
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 181 | $39,423 | $12,418 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $22,591 | $6,528 | 28.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 55 | 72 | $20,215 | $6,065 | 30.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 68 | 82 | $19,016 | $5,710 | 30.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 79 | 123 | $25,652 | $4,788 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $6,554 | $2,165 | 33.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 57 | 312 | $14,941 | $1,720 | 11.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 42 | $5,864 | $1,672 | 28.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 18 | $2,270 | $719.93 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 60 | $11,736 | $3,901 | 33.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 43 | 53 | $11,342 | $3,586 | 31.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 25 | 34 | $9,112 | $2,924 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $9,546 | $2,797 | 29.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 38 | 59 | $12,971 | $2,278 | 17.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 32 | 213 | $12,517 | $1,219 | 9.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 28 | $3,752 | $1,150 | 30.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 17 | 25 | $2,875 | $1,067 | 37.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $2,296 | $492.51 | 21.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 24 | 24 | $5,886 | $2,304 | 39.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 20 | 20 | $4,280 | $1,665 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 16 | $3,168 | $1,244 | 39.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 13 | $2,886 | $568.80 | 19.7% |
About Dr. Nour Al-Hadidi, MD
Dr. Nour Al-Hadidi, MD is a Dermatology healthcare provider based in Itasca, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1285014860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nour Al-Hadidi, MD has received a total of $4,629 in payments from pharmaceutical and medical device companies, with $852.89 received in 2024. These payments were reported across 160 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,472).
As a Medicare-enrolled provider, Al-Hadidi has provided services to 866 Medicare beneficiaries, totaling 1,531 services with total Medicare billing of $66,981. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Itasca, IL
- Active Since 06/09/2015
- Last Updated 07/02/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1285014860
Products in Payments
- RINVOQ (Biological) $632.62
- Otezla (Drug) $574.58
- SKYRIZI (Biological) $488.85
- DUPIXENT (Biological) $463.40
- OPZELURA (Drug) $361.29
- Humira (Biological) $292.26
- TREMFYA (Drug) $273.42
- TALTZ (Drug) $246.77
- HUMIRA (Biological) $155.41
- Skyrizi (Biological) $132.98
- Zoryve (Drug) $122.54
- Bimzelx (Biological) $111.63
- ILUMYA (Biological) $97.19
- AMELUZ (Drug) $89.54
- Tremfya (Drug) $76.99
- Cimzia (Drug) $57.45
- AKLIEF (Drug) $48.85
- ADBRY (Biological) $40.07
- Winlevi (Drug) $32.36
- AMZEEQ (Drug) $28.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.